-
Gilead Sciences is developing easier-to-administer versions of its antiviral treatment remdesivir for COVID-19 that could be used outside of hospitals, including ones that can be inhaled, after trials showed moderate effectiveness for the drug given by infusion. Remdesivir is the only drug so far that has been shown to help patients with COVID-19, but Gilead …
-
Shares of Pfizer fell nearly 7 percent on Monday after an independent data monitoring committee determined the drugmaker’s breast cancer treatment was unlikely to meet the main goal of a late-stage study. The treatment, Ibrance, was being tested along with the standard of care for early breast cancer in men and women, against standard of …
-
The CEO of pharmaceutical giant Merck on Monday said he watched the videotape of George Floyd being killed by a white officer with the knowledge that it “could be me.” “What the African American community sees in that videotape is that this African American man, who could be me or any other African American man, …
-
US health regulators are telling five drugmakers to recall their versions of a widely used diabetes medication after laboratory tests found elevated levels of a contaminant linked to cancer. The Food and Drug Administration said late Thursday that several batches of the drug metformin tested positive for unsafe levels of N-Nitrosodimethylamine, a possible cancer-causing chemical …
-
Naomi Campbell is using beauty to boost her spirits during the coronavirus pandemic. Besides taking extra precautions with hazmat suits, vitamins and more to protect herself from the virus, the model, 50, is also turning to makeup to lift her mood. “I wear lipstick everyday. I wear lipstick or one of the lip pencils, every …
-
The chief executive of AstraZeneca, which is developing a leading coronavirus vaccine with Oxford University, said it is too early to deliberately expose trial participants to the pathogen, but it may become an option if ongoing tests hit a snag. The British drugmaker last week started phase 2 and 3 trials of the vaccine, looking …
-
Wanda Sykes skewered Scott Baio after the “Charles in Charge” star came after her for defending Joe Biden in light of his controversial “you ain’t black” remarks. Baio, a vocal President Trump supporter, blasted the comedian on Twitter last Friday. “Hey @iamwandasykes why is it okay for @JoeBiden to say something clearly racist but @therealroseanne …
-
US stock indexes rose at the open on Wednesday as a pickup in business activity fueled hopes of a post-pandemic economic recovery, but marts later gave up some of their gains as investors remained cautious about brewing US-China tensions. The Dow Jones industrial average rose 303.52 points, or 1.21 percent, at the open to 25,298.63. …
-
Lana Del Rey shared some harsh assessments of her pop peers Beyoncé, Nicki Minaj, Ariana Grande — and many others — Thursday in a smack-talking Instagram post. The “Young and Beautiful” singer, 34, originally took to Insta to respond to accusations that her music romanticizes abusive relationships. The newly single Del Rey wrote, “I’m fed …
-
Jeffree Star is no stranger to controversy. And the YouTuber, 34, recently angered fans with the release of his death-themed “Cremated Collection” makeup palette, which many felt was insensitive to launch during the coronavirus pandemic. “It takes months and months and months, sometimes a year plus, to actually make a product,” Star said, addressing the …
Gilead Sciences is developing easier-to-administer versions of its antiviral treatment remdesivir for COVID-19 that could be used outside of hospitals, including ones that can be inhaled, after trials showed moderate effectiveness for the drug given by infusion. Remdesivir is the only drug so far that has been shown to help patients with COVID-19, but Gilead …
